SCHEMBL9732885

SCHEMBL9732885

CCOc1ccc2c(ccn2Cc2ccccc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ THRA P10827 1/20 0.51
▸ THRB P10828 1/20 0.51
▸ HDAC11 Q96DB2 2/20 0.48
▸ HDAC8 Q9BY41 2/20 0.48
▸ HDAC6 Q9UBN7 2/20 0.48
▸ HDAC3 O15379 1/20 0.48
▸ HDAC4 P56524 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC7 Q8WUI4 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HDAC10 Q969S8 1/20 0.48
▸ HDAC9 Q9UKV0 1/20 0.48
▸ HDAC5 Q9UQL6 1/20 0.48
▸ APP P05067 3/20 0.48
▸ KDM4C Q9H3R0 1/20 0.47
▸ KCNA3 P22001 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MAPK14 Q16539 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3193186 0.87 MAPK14 (0.61) NPC1HSP90AA1HDAC11HDAC8HDAC6
SCHEMBL2156618 0.87 HTR2C (0.56) NPC1HSP90AA1HDAC11HDAC8HDAC6
SCHEMBL2156900 0.81 PLA2G2A (0.56) NPC1HSP90AA1HDAC11HDAC8HDAC6
SCHEMBL6086123 0.81 MAPK14 (0.54) NPC1HSP90AA1MAPK14
SCHEMBL9194734 0.80 ROCK1 (0.54) NPC1HSP90AA1HDAC11HDAC8HDAC6
SCHEMBL5894002 0.80 MAPK14 (0.53) NPC1HSP90AA1HDAC8HDAC6HDAC3
SCHEMBL16783105 0.79 APP (0.52) NPC1HSP90AA1HDAC11HDAC8HDAC6
SCHEMBL24855125 0.79 NPC1 (0.50) NPC1HSP90AA1HDAC11HDAC8HDAC6
SCHEMBL30844613 0.79 NPC1 (0.50) NPC1HSP90AA1HDAC11HDAC8HDAC6
SCHEMBL6100496 0.79 ALOX5 (0.61) NPC1THRATHRBMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007829-A1 INDOLE-3-METHANAMINES USEFUL AS ANTI-DIABETIC, ANTI-OBESITY AND ANTI-ATHEROSCLEROTIC AGENTS THE UPJOHN COMPANY (US) 1992-05-14 — — WO disclosed
Send feedback